Drug intelligence / Profile preview

valsartan + chlorthalidone

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral
01

Overview

Valsartan + chlorthalidone is a fixed-dose combination of two antihypertensive agents used primarily for the treatment of high blood pressure (hypertension). Valsartan is an angiotensin II receptor blocker (ARB) that works by blocking the action of angiotensin II, leading to vasodilation and reduced blood pressure. Chlorthalidone is a thiazide-like diuretic that reduces fluid retention by increasing renal excretion of sodium and water, which also helps lower blood pressure. The combination provides additive antihypertensive effects and may offer improved 24-hour blood pressure control compared to monotherapy with either agent alone[4]. Both drugs are well-established in clinical use for hypertension management.

02

Targets

AGTR1 (Angiotensin II Type-1 receptor)SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on valsartan + chlorthalidone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on valsartan + chlorthalidone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call